UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy

Cell stem cell, 2015-07, Vol.17 (1), p.89-100

2015

Volltextzugriff (PDF)

Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell–Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome

Journal of the American College of Cardiology, 2016-11, Vol.68 (19), p.2086-2096

2016

Volltextzugriff (PDF)

Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant

Journal of the American College of Cardiology, 2018-07, Vol.72 (1), p.62-75

2018

Volltextzugriff (PDF)

Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3–Induced Myocarditis and Antiviral Drug Screening Platform

Circulation research, 2014-08, Vol.115 (6), p.556-566

2014

Volltextzugriff (PDF)

Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy

Nature (London), 2019-08, Vol.572 (7769), p.335-340

2019

Volltextzugriff (PDF)

Drug Screening Using a Library of Human Induced Pluripotent Stem Cell―Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity

Circulation (New York, N.Y.), 2013-04, Vol.127 (16), p.1677-1691

2013

Volltextzugriff (PDF)

Cardiovascular effects of immunosuppression agents

Frontiers in cardiovascular medicine, 2022-09, Vol.9, p.981838-981838

2022

Volltextzugriff (PDF)

Modeling Inherited Cardiac Disorders: A Cell Is Worth a Thousand Genes

Circulation Journal, 2014, Vol.78(4), pp.784-794

2014

Volltextzugriff (PDF)

Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy

Circulation (New York, N.Y.), 2021-08, Vol.144 (5), p.382-392

2021

Volltextzugriff (PDF)

Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene

Stem cell research, 2024-09, Vol.79, p.103485-103485, Article 103485

2024

Volltextzugriff (PDF)

Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations

Stem cell research, 2021-12, Vol.57, p.102605-102605, Article 102605

2021

Volltextzugriff (PDF)

Generation of induced pluripotent stem cell line from a patient suffering from arterial calcification due to deficiency of CD73 (ACDC)

Stem cell research, 2024-03, Vol.75, p.103285-103285, Article 103285

2024

Volltextzugriff (PDF)

Modeling Effects of Immunosuppressive Drugs on Human Hearts Using Induced Pluripotent Stem Cell-Derived Cardiac Organoids and Single-Cell RNA Sequencing

Circulation (New York, N.Y.), 2022-04, Vol.145 (17), p.1367-1369

2022

Volltextzugriff (PDF)

Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Cell reports (Cambridge), 2020-07, Vol.32 (2), p.107886-107886, Article 107886

2020

Volltextzugriff (PDF)

Generation of two iPSC lines from dilated cardiomyopathy patients with pathogenic variants in the SCN5A gene

Stem cell research, 2024-10, Vol.80, p.103498, Article 103498

2024

Volltextzugriff (PDF)

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations

Stem cell research, 2022-10, Vol.64, p.102928-102928, Article 102928

2022

Volltextzugriff (PDF)

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation

Stem cell research, 2023-10, Vol.72, p.103215, Article 103215

2023

Volltextzugriff (PDF)

Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation

Stem cell research, 2024-02, Vol.74, p.103265-103265, Article 103265

2024

Volltextzugriff (PDF)

Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients

Stem cell research, 2022-03, Vol.59, p.102657-102657, Article 102657

2022

Volltextzugriff (PDF)

Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C

Stem cell research, 2022-08, Vol.63, p.102834-102834, Article 102834

2022

Volltextzugriff (PDF)

Patient-Specific Induced Pluripotent Stem Cell–Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy

Circulation. Arrhythmia and electrophysiology, 2017-06, Vol.10 (6), p.e005398-e005398

2017

Volltextzugriff (PDF)

One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy

Frontiers in cardiovascular medicine, 2024-08, Vol.11, p.1429230

2024

Volltextzugriff (PDF)

Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene

Stem cell research, 2021-05, Vol.53, p.102284-102284, Article 102284

2021

Volltextzugriff (PDF)

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations

Stem cell research, 2021-08, Vol.55, p.102455-102455, Article 102455

2021

Volltextzugriff (PDF)

HIF1α Regulates Early Metabolic Changes due to Activation of Innate Immunity in Nuclear Reprogramming

Stem cell reports, 2020-02, Vol.14 (2), p.192-200

2020

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(100)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(45)
Humans
(36)
Cardiac & Cardiovascular Systems
(21)
Cardiovascular System & Cardiology
(21)
Induced Pluripotent Stem Cells
(14)
Stem Cells
(14)
Cell Biology
(13)
Male
(12)
Cell & Tissue Engineering
(11)
Biotechnology & Applied Microbiology
(9)
Induced Pluripotent Stem Cells - Metabolism
(9)
Cell Differentiation
(8)
Female
(8)
Mutation
(8)
Adult
(7)
Animals
(7)
Cardiology
(7)
Cardiomyopathy
(6)
Cardiomyopathy, Dilated - Genetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy

Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell–Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome

Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant

Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3–Induced Myocarditis and Antiviral Drug Screening Platform

Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy

Drug Screening Using a Library of Human Induced Pluripotent Stem Cell―Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity

Cardiovascular effects of immunosuppression agents

Modeling Inherited Cardiac Disorders: A Cell Is Worth a Thousand Genes

Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy

Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene

Generation of two induced pluripotent stem cell lines from Brugada syndrome affected patients carrying SCN5A mutations

Generation of induced pluripotent stem cell line from a patient suffering from arterial calcification due to deficiency of CD73 (ACDC)

Modeling Effects of Immunosuppressive Drugs on Human Hearts Using Induced Pluripotent Stem Cell-Derived Cardiac Organoids and Single-Cell RNA Sequencing

Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Generation of two iPSC lines from dilated cardiomyopathy patients with pathogenic variants in the SCN5A gene

Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation

Generation of two induced pluripotent stem cell lines from hereditary amyloidosis patients with polyneuropathy carrying heterozygous transthyretin (TTR) mutation

Heterozygous LMNA mutation-carrying iPSC lines from three cardiac laminopathy patients

Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C

Patient-Specific Induced Pluripotent Stem Cell–Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy

One-year real-world experience with mavacamten and its physiologic effects on obstructive hypertrophic cardiomyopathy

Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene

Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations

HIF1α Regulates Early Metabolic Changes due to Activation of Innate Immunity in Nuclear Reprogramming

Suchergebnisse filtern